glp-1 therapy WHO Endorses GLP‑1 Obesity Care: Implications for Diabetes Providers 3 Takeaways from the Landmark
Description
AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review
Hanzelmann, S., Castelo, R
Lancet 403(10437):16351648
one of the underlying drivers of PCOS symptoms
Exenatide was well tolerated in patients and rates of hypoglycemia were relative low in these studies
Depending on the HbA 1c and comorbidities, specialist advice may be needed at this time
